2024-10-01T11:35:31-05:00 2023-12-31 750786316 WEAVER AND TIDWELL LLP 2300 N FIELD ST STE 1000 DALLAS TX 75201 990 2023-01-01 510151514 RETINA FOUNDATION OF THE SOUTHWEST RETI 2143633911 PO BOX 824189 DALLAS TX 753824189 NAOMI EMMETT CHIEF FINANCIAL & BUSINESS OFFICER 2143633911 2024-09-30 1 0 SARA BURKHART P01435955 9724901970 2023 2024-10-15 13:58:12Z NAOMI EMMETT PO BOX 824189 DALLAS TX 753824189 7986271 0 X WWW.RETINAFOUNDATION.ORG X 1975 TX THE FOUNDATION WAS ORGANIZED TO PROMOTE THE RESEARCH, DIAGNOSIS, TREATMENT AND EDUCATION OF THE LEADING CAUSES OF BLINDNESS AND IMPAIRED VISION. THE FOUNDATION ALSO STRIVES TO INCREASE THE UNDERSTANDING OF THE NORMAL DEVELOPMENT AND FUNCTION OF THE VISUAL SYSTEM IN ORDER TO PREVENT, DIAGNOSE AND TREAT SIGHT-THREATENING CONDITIONS, AND TO ENHANCE THE REHABILITATION, TRAINING AND QUALITY OF LIFE OF INDIVIDUALS WHO ARE PARTIALLY SIGHTED OR BLIND. 19 19 42 23 0 0 5583143 7603799 0 0 70614 322832 -68993 -80221 5584764 7846410 0 1764989 0 0 3724894 4015818 0 0 771539 1757093 2020394 5481987 7801201 102777 45209 13298686 13241837 1040287 938229 12258399 12303608 THE MISSION OF THE RETINA FOUNDATION OF THE SOUTHWEST IS TO PREVENT VISION LOSS AND RESTORE SIGHT THROUGH INNOVATIVE RESEARCH AND TREATMENT. 0 0 6205219 1764989 STUDIES TO OPTIMIZE VISUAL OUTCOMES FOR CHILDREN WITH CONGENITAL AND EARLY-ONSET EYE CONDITIONS AND ULTIMATELY DEVELOP MORE SUCCESSFUL AND EFFECTIVE METHODS FOR EARLY SCREENING, TREATMENTS, AND ADHERENCE. RESEARCH INTO INNOVATIVE NEW TREATMENTS FOR INHERITED RETINAL DEGENERATIVE DISEASES, SUCH AS RETINITIS PIGMENTOSA. COLLECTING AND MAINTAINING CLINICAL AND GENETIC DATA FOR INDIVIDUALS WITH INHERITED EYE DISEASES. CONDUCT VARIOUS TYPES OF RESEARCH TO BETTER UNDERSTAND AGE-RELATED MACULAR DEGENERATION, DEVELOP WAYS TO SLOW THE PROGRESSION, AND DISCOVER BETTER TREATMENT OPTIONS. 6205219 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 1 1 0 0 0 0 0 0 0 1 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 0 0 1 60 0 1 42 1 0 0 0 0 0 0 0 0 0 0 0 0 X 19 19 1 0 1 0 0 0 0 1 1 0 0 0 1 1 1 1 1 1 1 0 X NAOMI EMMETT 2143633911 PO BOX 824189 DALLAS TX 753824189 RAJIV ANAND MD DIRECTOR 1.00 X 0 0 0 DIANE BODDY DIRECTOR 1.00 X 0 0 0 MEHMET CANDAS PHD DIRECTOR 1.00 X 0 0 0 ALEX M CENA DIRECTOR 1.00 1.00 X 0 0 0 LORI DAO MD DIRECTOR 1.00 X 0 0 0 LAURIE DOTTER CPA DIRECTOR 1.00 X 0 0 0 REHAM EL-SHERAZI CPA DIRECTOR 1.00 X 0 0 0 WILLIAM L HUTTON MD DIRECTOR 1.00 1.00 X 0 0 0 MARC H KLEIN DIRECTOR 1.00 X 0 0 0 RICHARD A MASSMAN DIRECTOR 1.00 1.00 X 0 0 0 JAMES H MERRITT MD DIRECTOR 1.00 X 0 0 0 MICKEY MUNIR DIRECTOR 1.00 X 0 0 0 EVELYN J PULLIAM DIRECTOR 1.00 X 0 0 0 THERESE ROURK DIRECTOR 1.00 X 0 0 0 RICHARD SCHAAR PHD DIRECTOR 1.00 X 0 0 0 TIA S TOMLIN DIRECTOR 1.00 X 0 0 0 STEVEN EISNAUGLE TREASURER 1.00 X X 0 0 0 LOUIS GRABOWSKY CHAIR 1.00 1.00 X X 0 0 0 NANCY ROGERS SECRETARY 1.00 X X 0 0 0 KARL CSAKY CHIEF EXECUTIVE AND MEDICAL OFFICER 29.00 1.00 X 429467 0 16736 NATALIE GILBERT FINANCE DIRECTOR 39.00 1.00 X 133512 0 16084 NAOMI EMMETT CFO/CBO 40.00 X 29158 0 772 DAVID BIRCH SCIENTIFIC DIRECTOR 40.00 X 310322 0 24915 EILEEN BIRCH PEDIATRIC DIRECTOR 40.00 X 303475 0 24573 AMY JOHNSON CHIEF DEVELOPMENT OFFICER 40.00 X 184713 0 18639 CINDY BAILLIE OPERATIONS MANAGER 40.00 X 125926 0 15704 KIRSTEN LOCKE CLINICAL TRIALS MANAGER 40.00 X 114390 0 15118 SRINIVASA SRIPATHI LAB DIRECTOR 36.00 X 111178 0 16769 1742141 0 149310 8 0 1 0 0 633003 386531 645637 5938628 7603799 322832 322832 27600 633003 139861 -112261 -112261 OTHER INCOME 900099 32040 32040 32040 7846410 0 0 242611 1764989 1764989 1302971 1049309 212262 41400 2194697 1559183 308462 327052 95152 64586 14361 16205 206019 151430 30027 24562 216979 156790 36189 24000 47263 21609 25010 644 56426 56426 123657 57514 21212 44931 184054 40752 143302 238872 150029 38681 50162 67198 49294 8821 9083 179280 142601 11937 24742 57407 50244 2994 4169 21973 17578 1099 3296 279654 245027 10912 23715 62762 44228 16196 2338 DIRECT PROGRAM EXPENSES 465225 465225 OTHER EXPENSES 118676 56884 29854 31938 BAD DEBT EXPENSE 70000 70000 LECTURE SERIES 47947 47947 7801201 6205219 824443 771539 30903 73441 7461268 6680938 1578492 2394520 59063 40861 6666195 2614118 4168960 4052077 13298686 13241837 619971 311936 46507 105000 373809 521293 1040287 938229 X 7577911 6461421 4680488 5842187 12258399 12303608 13298686 13241837 45209 0 X X 0 1 X 1 0 X 5217266 5759915 5275882 5596830 7603799 29453692 5217266 5759915 5275882 5596830 7603799 29453692 5499630 23954062 394698 286857 1974 70614 322832 1076975 65771 72754 33560 32483 32040 236608 30767275 0.77860 0.74170 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 10397738 111335 10509073 10097769 682666 382697 10397738 8845554 1622105 369890 10097769 250000 250000 3404273 948344 2455929 3011922 1665774 1346148 4052077 X 7941148 0 7941148 -94738 -94738 7846410 7895939 94738 94738 7801201 0 7801201 PART X, LINE 2: THE FOUNDATION HAS BEEN RECOGNIZED BY THE INTERNAL REVENUE SERVICE AS A NONPROFIT CORPORATION EXEMPT FROM FEDERAL INCOME TAX ON ITS INCOME, UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE. THE FOUNDATION FOLLOWS THE PROVISIONS OF ASC 740-10, INCOME TAXES, RELATED TO UNRECOGNIZED TAX POSITIONS. THE FOUNDATION RECOGNIZES THE TAX BENEFITS FROM UNCERTAIN TAX POSITIONS ONLY IF IT IS MORE LIKELY THAN NOT THAT THE TAX POSITIONS WILL BE SUSTAINED ON EXAMINATION BY THE TAXING AUTHORITIES, BASED ON THE TECHNICAL MERITS OF THE POSITIONS. THE TAX BENEFITS RECOGNIZED IN THE FINANCIAL STATEMENTS FROM SUCH POSITIONS ARE MEASURED BASED ON THE LARGEST BENEFIT THAT HAS A GREATER THAN 50% LIKELIHOOD OF BEING REALIZED UPON ULTIMATE SETTLEMENT. THE FOUNDATION DOES NOT BELIEVE THERE ARE ANY MATERIAL UNCERTAIN TAX POSITIONS AND ACCORDINGLY, IT WILL NOT RECOGNIZE ANY LIABILITY FOR UNRECOGNIZED TAX BENEFITS. FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022, THERE WERE NO INTEREST OR PENALTIES RECORDED OR INCLUDED IN THE FINANCIAL STATEMENTS. THE FOUNDATION IS RELYING ON ITS TAX-EXEMPT STATUS AND ITS ADHERENCE TO ALL APPLICABLE LAWS AND REGULATIONS TO PRESERVE THAT STATUS. HOWEVER, THE CONCLUSIONS REGARDING ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES WILL BE SUBJECT TO REVIEW AND MAY BE ADJUSTED AT A LATER DATE BASED ON FACTORS INCLUDING, BUT NOT LIMITED TO, ONGOING ANALYSIS OF TAX LAWS, REGULATIONS, AND INTERPRETATIONS THEREOF. THE FOUNDATION'S INFORMATIONAL RETURNS ARE GENERALLY SUBJECT TO EXAMINATION FOR THREE YEARS AFTER THE LATER OF THE DUE DATE OR DATE OF FILING. AS A RESULT, THE FOUNDATION IS NO LONGER SUBJECT TO INCOME TAX EXAMINATIONS BY TAX AUTHORITIES FOR YEARS PRIOR TO 2020. PART XI, LINE 4B - OTHER ADJUSTMENTS: DIRECT EXPENSES FOR FUNDRAISING EVENT -94,738. PART XII, LINE 2D - OTHER ADJUSTMENTS: DIRECT EXPENSES FOR FUNDRAISING EVENT 94,738. VISIONARY LUNCHEON 660603 633003 27600 45123 94738 660603 633003 27600 45123 94738 139861 -112261 0 RFSW ENDOWMENT INC PO BOX 824189 DALLAS TX 753824189 851208107 501(C)(3) 1764989 0 GENERAL FUNDING 1 X X 0 0 0 0 0 0 0 0 0 KARL CSAKY CHIEF EXECUTIVE AND MEDICAL OFFICER 360467 0 0 0 69000 0 16500 0 236 0 446203 0 0 0 DAVID BIRCH SCIENTIFIC DIRECTOR 306572 0 0 0 3750 0 15516 0 9399 0 335237 0 0 0 EILEEN BIRCH PEDIATRIC DIRECTOR 303475 0 0 0 0 0 15174 0 9399 0 328048 0 0 0 AMY JOHNSON CHIEF DEVELOPMENT OFFICER 184713 0 0 0 0 0 9236 0 9403 0 203352 0 0 0 FORM 990, PART VI, SECTION A, LINE 2 DAVID BIRCH AND EILEEN BIRCH HAVE A FAMILY RELATIONSHIP. THEY ARE BOTH KEY EMPLOYEES. FORM 990, PART VI, SECTION A, LINE 4 THE BYLAWS HAVE BEEN UPDATED TO INCLUDE THE FOLLOWING SUMMARIZED SIGNIFICANT CHANGES: 1. THE FOLLOWING STANDING COMMITTEES WERE REMOVED: COMPENSATION COMMITTEE DEVELOPMENT COMMITTEE INVESTMENT COMMITTEE SCIENTIFIC REVIEW COMMITTEE 2. THE TENURE COMMITTEE WAS ADDED AS AN ADVISORY COMMITTEE ONLY 3. WITH THE ELIMINATION OF THE COMPENSATION COMMITTEE, THE EXECUTIVE COMMITTEE WILL ASSUME THE ROLE OF REVIEWING AND ADVISING ON THE COMPENSATION MODIFICATIONS OF RETINA FOUNDATION STAFF, SENIOR MANAGEMENT, AND RESEARCHERS. 4. REFERENCE TO THE NEW CHIEF FINANCIAL OFFICER POSITION WAS INCLUDED. 5. THE DESCRIPTIONS OF DUTIES FOR THE SECRETARY AND TREASURER WERE REVISED. 6. THE "GIFTS" PROVISION HAS BEEN REVISED TO REFERENCE THE RETINA FOUNDATION GIFT ACCEPTANCE POLICY, WHICH THE GOVERNANCE COMMITTEE WILL PREPARE AND PRESENT TO THE BOARD FRO APPROVAL. 7. THERE ARE A NUMBER OF "CLEANING UP" REVISIONS INVOLVING INCONSISTENT REFERENCES, OUTDATED REFERENCES, AND CLARIFYING LANGUAGE. FORM 990, PART VI, SECTION B, LINE 11B FORM 990 IS REVIEWED BY MEMBERS OF THE FINANCE AND AUDIT COMMITTEE PRIOR TO FILING. FORM 990, PART VI, SECTION B, LINE 12C CONFLICTS OF INTEREST ARE ADDRESSED IN THE BOARD MEETINGS. MEMBERS MUST SIGN THE CONFLICT OF INTEREST STATEMENT ANNUALLY. FORM 990, PART VI, SECTION B, LINE 15 THE COMPENSATION COMMITTEE MEETS EVERY YEAR AND EVALUATES AND APPROVES THE COMPENSATION OF THE KEY EMPLOYEES. A PART OF THIS PROCESS INCLUDES COMPARING THEM TO OTHER INSTITUTIONS LIKE THE RETINA FOUNDATION OF THE SOUTHWEST. FORM 990, PART VI, SECTION C, LINE 19 THE FOUNDATION'S DOCUMENTS ARE AVAILABLE AT WWW.GUIDESTAR.ORG AND UPON REQUEST. FORM 990, PART XII, LINE 2C THERE HAS BEEN NO CHANGE IN THE OVERSIGHT OR SELECTION PROCESS OF THE INDEPENDENT ACCOUNTANT IN THE PAST YEAR. RFSW ENDOWMENT INC PO BOX 824189 DALLAS TX 753824189 851208107 INVESTMENTS TX 501(C)(3) LINE 7 RETINA FOUNDATION OF THE SOUTHWEST 1 0 1 1 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 RFSW ENDOWMENT INC B 1764989 CASH RFSW ENDOWMENT INC C 386531 CASH